Czechia· CZ-0238121
MEDOCLAV
A amoxicillin und beta-lactamase-inhibitor product containing amoxicillin trihydrate + potassium clavulanate and microcristalline cellulose, registered in Czechia by Medochemie Bohemia, spol. s r.o., Praha. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Amoxicillin und beta-lactamase-inhibitor is registered in 13 of 19 countries.
Countries holding a registration under ATC J01CR02 (amoxicillin und beta-lactamase-inhibitor), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Amoxicillin und beta-lactamase-inhibitor · ATC J01CR02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of amoxicillin und beta-lactamase-inhibitor costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.28 in Italy to $5.60 in Switzerland — a ×4.4 gap.
- Czechia: $1.42 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Amoxicillin und beta-lactamase-inhibitor · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$5.60
- ES Spain$4.65
- CZ Czechia$1.42
- IT Italy$1.28
The record
At a glance
SÚKL (Czech Republic)- Active substance
- AMOXICILLIN TRIHYDRATE + POTASSIUM CLAVULANATE AND MICROCRISTALLINE CELLULOSE
- Manufacturer
- Medochemie Bohemia, spol. s r.o., Praha
- Country
- Czechia (CZ)
- ATC code
- J01CR02
- ATC class
- Amoxicillin und Beta-Lactamase-Inhibitor
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
24 interactions on record for amoxicillin und beta-lactamase-inhibitor.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amoxicillin und beta-lactamase-inhibitor · interactions on record
24 records
- 4 severe
- 17 moderate
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01CR02
Amoxicillin und beta-lactamase-inhibitor, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4770b2d-b9b2-4bd5-8cfa-2f222c5615af GET /v1/drugs/c4770b2d-b9b2-4bd5-8cfa-2f222c5615af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "875MG/125MG",
"pack_size": "4",
"substance": "AMOXICILLIN TRIHYDRATE + POTASSIUM CLAVULANATE AND MICROCRISTALLINE CELLULOSE",
"cz_kod_sukl": "0238121",
"product_type": "CH",
"substance_codes": "9563,18549",
"registration_state": "R",
"registration_number": "15/173/17-C"
}See everything about amoxicillin und beta-lactamase-inhibitor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.